Malangizo 4 Kuchiza, ndi Kupewa, Kuphulika
Malinga ndi mtundu wa khungu kapena mtundu, ziphuphu sizimasankha: Anthu omwe ali ndi khungu la African-American (kapena omwe ali ndi midzi yofiira mpaka mdima chifukwa cha mtundu wina) ali ngati amodzi omwe ali ndi khungu loyera. Komabe, pali kusiyana kwakukulu kochepa pa momwe zizindikiro zimakhudzidwira khungu la mtundu, malinga ndi zomwe zinalembedwa mu Journal of Clinical and Aesthetic Dermatology mu 2010.
Chifukwa chimodzi, mu khungu lakuda nthawi zambiri kutupa kumapezeka ngakhale m'matumbo omwe nthawi zambiri amawoneka ngati "osapsa." Ndipo nthawi zina ziphuphu zomwe zimakhala zotupa, zimatha kusiya mdima wandiweyani. Izi zimatchedwa post-inflammatory hyperpigmentation (PIH) ndipo zimachitika chifukwa kutupa kumayambitsa maselo a khungu kuti apangitse khansa yambiri, zomwe zimapereka khungu, malinga ndi American Academy of Dermatology (AAD).
Choncho ngati muli ndi khungu lakuda kapena lakuda lomwe limakhala ndi ziphuphu, izi ndi zinthu zochepa zomwe muyenera kuziganizira pazomwe mukuchita ndi kupuma.
1 -
Sankhani mankhwala opatsirana mosamala.Zikuwoneka kuti khungu lofiira kapena lakuda silikhala lopweteka kusiyana ndi khungu loyera koma izi siziri choncho konse. Khungu lakuda limangokhala lopwetekedwa ndi mankhwala opatsirana pogonana, monga kuyanika kwambiri. Retinoids, kuphatikizapo Retin-A (tretinoin topical), Differin (adapalene), ndi Tazorac (tazarotene) amaonedwa kuti ndi zosankha zabwino za mnofu wa mdima chifukwa amachiza mavuto a mtundu wa nkhuku pamene akuchotseratu.
2 -
Yang'anani kusintha kwa mtundu wa khungu.Nthenda yomwe ingachiritse kwathunthu kwa munthu yemwe ali ndi khungu loyera nthawi zambiri amasiya chilema chakuda kwa munthu yemwe ali ndi khungu lakuda. Mankhwala ena amatsenga angayambitsenso mdima kapena kutsegula (hypopigmentation) khungu, monga peels, mankhwala a laser, ndi microdermabrasion. Ngati mukuganiza kuti mupite ku salon kuti muwone nkhope yanu, yeretsani ndi dermatologist poyamba. Kenaka onetsetsani kuti katswiri wazam'mawa kapena wodwala wa khungu amadziwira khungu la mtundu: Musawope kufunsa.
3 -
Musachedwe kuchita ndi kupuma.Pangani nthawi yoti muwonetsetse dokotala wa mankhwala ngakhale mutakhala ndi mpweya wofewa (kapena mtundu uliwonse wa khungu, monga rosacea). Iyi ndi njira yabwino kwambiri yothetsera mavuto a pigment. Ndipotu, maphunziro a AAD, amaphunziro amathandiza kufunika kochizira nthendayi pamene ikuyamba. Ngati kupuma kumaloledwa kukhala ochepa kwambiri, munthu yemwe ali ndi khungu lakuda amayamba kuopsa kuti asamangokhala ndi mdima kapena mabala, koma ndi mtundu wina wofiira wotchedwa keloid.
4 -
Khalani otetezeka.Mofanana ndi mavuto ambiri azaumoyo, kuchita zonse zomwe mungathe kuti muteteze nthendayi ndi bwino kuposa kuyembekezera kupuma ndikuyesera kuchiza. Nawa malangizi ochokera ku AAD pofuna kusunga maulendo omwe akuyang'ana anthu omwe ali ndi khungu lakuda:
- Ngati mumakonda kukhala ndi ziphuphu pamphumi kapena kumutu ndipo mumagwiritsa ntchito mankhwala osamalira tsitsi, muzigwiritsira ntchito pakati pa khungu lanu ndi kumapeto kwa tsitsi lanu, kapena yesetsani kugwiritsira ntchito glycerin kapena madzi. Ngati nthawi zonse mumabvala chipewa kapena chipewa, chotsani kawirikawiri kuti muteteze thukuta, dothi, ndi mafuta kumanga khungu lanu.
- Musagwiritse ntchito mankhwala osamala a khungu omwe angathe kutseka khungu lanu. Pewani mafuta omwe ali ndi mafuta a cocoa kapena batala ya shea, mwachitsanzo, ndipo m'malo mwake musankhe anthu omwe amatchedwa "non-comedogenic" kapena "asadzatseke pores."
- Gwiritsani ntchito zojambula zamchere kapena zosakhala comedogenic kuti muphimbe zofooka.
- Onetsani nkhope yanu TLC mukamatsuka. Gwiritsani ntchito kuyeretsa kofatsa, kuzigwiritsanso pang'ono pang'onopang'ono, ndipo mutatha kuchapa, musamalitse-khungu lanu liume ndi thaulo yoyera.
> Zotsatira:
> American Academy of Dermatology. "Zokuthandizani 10 kuti Muchotse Akne M'khungu la Mtundu." Nov 17, 2016.
> Erica C. Davis, MD ndi Valerie D. Callender, MD. "Kubwereza za Nyamakazi M'khungu Lanyama." J Clin Aesthet Dermatol . 2010 Apr 3 (4): 24-38.